Get the Stockscreener App
1.585
0.93%
-0.02
Cibus Inc stock is traded at $1.585, with a volume of 20,547.
It is down -0.93% in the last 24 hours and up +20.91% over the past month.
Cibus Inc is a biotechnology company. The company develops and commercializes a proprietary gene-editing technology, Rapid Trait Development System that integrates crop specific cell biology platforms with a series of gene editing technologies. The company's primary business is the development of plant traits that help address specific productivity or yield challenges in farming such as traits addressing plant agronomy, disease, insects, weeds, nutrient-use, or the climate.
See More
Previous Close:
$1.605
Open:
$1.6
24h Volume:
20,547
Relative Volume:
0.06
Market Cap:
$83.54M
Revenue:
$1.82M
Net Income/Loss:
$-267.63M
P/E Ratio:
-0.0786
EPS:
-20.1639
Net Cash Flow:
$-50.53M
1W Performance:
+16.91%
1M Performance:
+20.91%
6M Performance:
+2.58%
1Y Performance:
-59.70%
1-Day Range:
$1.5601
$1.60
1-Week Range:
$1.31
$1.62
52-Week Range:
$1.09
$4.94
Cibus Inc Stock (CBUS) Company Profile
Name
Cibus Inc
Sector
Industry
Phone
(858) 450-0008
Address
6455 NANCY RIDGE DRIVE, SAN DIEGO
Compare CBUS with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CBUS
Cibus Inc
|
1.585 | 84.86M | 1.82M | -267.63M | -50.53M | -20.16 |
|
VRTX
Vertex Pharmaceuticals Inc
|
458.70 | 116.04B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
729.43 | 75.97B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
462.33 | 61.48B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
904.45 | 56.40B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
204.81 | 43.73B | 447.02M | -1.18B | -906.14M | -6.1812 |
Cibus Inc Stock (CBUS) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-29-24 | Initiated | Alliance Global Partners | Buy |
| Jul-19-24 | Resumed | Canaccord Genuity | Buy |
| Oct-09-23 | Initiated | H.C. Wainwright | Buy |
| Jul-19-23 | Resumed | Canaccord Genuity | Buy |
Cibus Inc Stock (CBUS) Latest News
What drives Cibus Inc stock priceStock Valuation Metrics & Free High Frequency Trading Ideas - earlytimes.in
Cibus (CBUS) Total Equity : $52.03 Mil (As of Sep. 2025) - GuruFocus
Cibus (NASDAQ:CBUS) and Brasilagro Cia Brasileira De Propriedades Agricolas (NYSE:LND) Critical Review - Defense World
Insider Sell: How Cibus Inc. stock responds to policy changesJuly 2025 Sector Moves & Precise Trade Entry Recommendations - moha.gov.vn
Cibus director Gerhard Prante sells $2,817 in stock - MSN
Cibus CBUS grants director 45,627 options expiring in 2035 - Stock Titan
[Form 3] Cibus, Inc. Initial Statement of Beneficial Ownership - Stock Titan
Cibus (CBUS) Other Stockholders Equity : $0.00 Mil (As of Sep. 2025) - GuruFocus
Cibus director Prante Gerhard sells $2,875 in stock - MSN
Cibus, Inc. Experiences Revision in Its Stock Evaluation Amid Mixed Financial Performance - Markets Mojo
What is the fair value of Cibus Inc. stock nowMarket Risk Report & Reliable Trade Execution Plans - newser.com
Is Cibus Inc. stock overvalued by current metricsPrice Action & AI Driven Stock Movement Reports - newser.com
Sidoti Csr Weighs in on Cibus' FY2025 Earnings (NASDAQ:CBUS) - MarketBeat
Cibus (CBUS) EBIT per Share : $-2.55 (TTM As of Sep. 2025) - GuruFocus
Will Cibus Inc. stock continue upward momentumWeekly Profit Report & Fast Gaining Stock Reports - newser.com
Cibus (CBUS) Price-to-Owner-Earnings : (As of Nov. 21, 2025) - GuruFocus
Can Cibus Inc. stock beat analyst upgradesQuarterly Investment Review & Low Risk Investment Opportunities - newser.com
Sidoti Csr Has Pessimistic View of Cibus FY2025 Earnings - Defense World
Is Cibus Inc. stock a top pick in earnings season2025 Volume Leaders & AI Powered Trade Plan Recommendations - newser.com
Sidoti Csr Forecasts Cibus' Q1 Earnings (NASDAQ:CBUS) - MarketBeat
Cibus, Inc. (NASDAQ:CBUS) Q3 2025 Earnings Call Transcript - MSN
Cibus Inc. stock trend forecastCEO Change & Entry Point Strategy Guides - newser.com
Will Cibus Inc. rebound enough to break evenJuly 2025 Reactions & Free Daily Entry Point Trade Alerts - newser.com
Will Cibus Inc. stock deliver shareholder valueEarnings Overview Report & Technical Pattern Based Signals - newser.com
How Cibus Inc. stock reacts to bond yieldsEarnings Miss & Expert Verified Movement Alerts - newser.com
Should you hold or exit Cibus Inc. nowBuy Signal & Momentum Based Trading Signals - newser.com
Best data tools to analyze Cibus Inc. stock2025 Market Overview & AI Forecast for Swing Trade Picks - newser.com
Heatmap analysis for Cibus Inc. and competitorsMarket Volume Report & Advanced Swing Trade Entry Plans - newser.com
How Cibus Inc. stock performs in interest rate cyclesJobs Report & Precise Swing Trade Alerts - newser.com
Can you recover from losses in Cibus Inc.Trade Performance Summary & Long-Term Capital Growth Ideas - newser.com
Cibus Inc Stock (CBUS) Financials Data
Revenue
Net Income
Cash Flow
EPS
Cibus Inc Stock (CBUS) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Prante Gerhard | Director |
Feb 24 '25 |
Sale |
2.07 |
1,150 |
2,380 |
8,857 |
| Prante Gerhard | Director |
Feb 21 '25 |
Sale |
2.20 |
1,150 |
2,530 |
10,007 |
| Prante Gerhard | Director |
Feb 20 '25 |
Sale |
2.35 |
1,150 |
2,702 |
11,157 |
| Prante Gerhard | Director |
Feb 19 '25 |
Sale |
2.58 |
1,150 |
2,967 |
12,307 |
| Prante Gerhard | Director |
Feb 18 '25 |
Sale |
2.52 |
2,300 |
5,796 |
13,457 |
| Prante Gerhard | Director |
Feb 14 '25 |
Sale |
2.60 |
1,150 |
2,990 |
15,757 |
| Prante Gerhard | Director |
Feb 13 '25 |
Sale |
2.53 |
1,150 |
2,910 |
16,907 |
| Prante Gerhard | Director |
Feb 12 '25 |
Sale |
2.45 |
1,150 |
2,818 |
18,057 |
| Prante Gerhard | Director |
Feb 11 '25 |
Sale |
2.48 |
1,150 |
2,852 |
19,207 |
| Prante Gerhard | Director |
Feb 10 '25 |
Sale |
2.52 |
1,150 |
2,898 |
20,357 |
0.29%
0.67%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):